Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Providing Appropriate Medical Care for IBD Patients Release Date: Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD) | Quality Improvement | Inflammation & Immunology | Japan | |
Improving the Care Process for Patients with Advanced Prostate Cancer Release Date: Partner: The American Urological Association Education and Research, Inc.; Astellas | Quality Improvement | Oncology | USA | |
Optimizing Care for patients with locally advanced or metastatic Urothelial Carcinoma (la/mUC) Release Date: | Quality Improvement | Oncology | Canada | |
PARP-Inhibitor Combination Therapies: Personalized Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer Release Date: | Education | Oncology | Canada | |
Developing Educational Initiatives for ALK+ Metastatic Non-small Cell Lung Cancer Tyrosine Kinase Inhibitors Therapy Release Date: | Education | Oncology | Canada | |
Accelerating biomarker testing for optimized metastatic colorectal cancer treatment planning across Canada Release Date: Partner: Colorectal Cancer Canada (CCC) | Quality Improvement, Research | Oncology | Canada | |
Integrin beta-6 (IB6) Sigvotatug Vedotin (SV) Translational and Pre-Clinical Research Release Date: | Research | Oncology | All | |
2025 Inflammatory Bowel Disease (IBD) Fellowship – United States Release Date: | Fellowship | Inflammation & Immunology | USA | |
PARP-inhibitor Combination Treatments: Efficacy and Safety in a New Era of metastatic Castration Resistant Prostate Cancer Release Date: | Education | Oncology | China | |
Transthyretin Cardiac Amyloidosis Fellowship - United States Release Date: | Fellowship | Rare Disease | USA | |
Advances in Migraine Management Release Date: | Education | Internal Medicine | USA |
Title | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Pneumococcal Disease Prevention Release Date: | ||||
Chronic Pain Release Date: | ||||
Bacterial Infections Release Date: | ||||
Pharmacy Pneumococcal Disease Prevention Release Date: | ||||
Smoking Cessation Release Date: | ||||
Non-Small Cell Lung Cancer Release Date: | ||||
Cardiovascular Risk in Rheumatoid Arthritis Release Date: | ||||
Opioid Pain Release Date: | ||||
Adult Pneumococcal Disease Prevention Release Date: | ||||
Prevention of Stroke in Women Release Date: | ||||
Oncology Educational Needs Assessments Release Date: | ||||
Extension Grant Release Date: |